| abstract |
The present invention provides antibodies that bind to human GFRα3 and methods of using the same. According to certain embodiments disclosed herein, the antibody is a fully human antibody that binds to human GFRα3. The antibodies of the present disclosure are useful for the treatment of diseases or disorders associated with one or more GFRα3 biological activities, including treatment of acute or chronic pain diseases, or inflammatory diseases. |